CEROW logo

CEROW EBITDA

Annual EBITDA

-$10.90 M
-$17.56 K-0.16%

December 31, 2022

Summary

Performance

1-Year Change

-0.16%

3-Year Change

-0.16%

5-Year Change

-0.16%

15-Year Change

-0.16%

CEROW EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$10.88 M

3-Year Low

-$10.90 M
CEROW annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CEROW previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CEROW next annual earnings announcement has not yet been scheduled

OtherCEROWprofitabilitymetrics:

Annual Revenue

$0.00
CEROW annual revenue is $0.00

Annual Net Income

-$11.83 M
CEROW annual net profit is -$11.83 million

Annual EBIT

-$11.97 M
CEROW annual earnings before interest & taxes is -$11.97 million

Annual EPS

-
CEROW annual earnings per share value is unknown

Quarterly EBITDA

-$4.57 M
+$1.21 M+20.88%

September 30, 2024

Summary

Performance

3-Month Change

+20.88%

1-Year Change

+20.88%

3-Year Change

-111.21%

5-Year Change

-111.21%

CEROW Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.44 M

3-Year Low

-$5.78 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CEROW previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
CEROW next earnings announcement has not yet been scheduled

OtherCEROWprofitabilitymetrics:

Quarterly Revenue

$0.00
CEROW quarterly revenue is $0.00

Quarterly Net Income

-$4.23 M
CEROW quarterly net profit is -$4.23 million

Quarterly EBIT

-$4.40 M
CEROW quarterly earnings before interest & taxes is -$4.40 million

Quarterly EPS

-
CEROW quarterly earnings per share value is unknown

TTM EBITDA

-$10.35 M
-$3.13 M-43.38%

September 30, 2024

Summary

Performance

3-Month Change

-43.38%

1-Year Change

-43.38%

3-Year Change

-378.17%

5-Year Change

-378.17%

CEROW TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$2.16 M

3-Year Low

-$10.35 M
CEROW TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CEROW previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
CEROW next earnings announcement has not yet been scheduled

OtherCEROWprofitabilitymetrics:

TTM Revenue

$0.00
CEROW TTM revenue is $0.00

TTM Net Income

-$6.68 M
CEROW TTM net profit is -$6.68 million

TTM EBIT

-$6.83 M
CEROW TTM earnings before interest & taxes is -$6.83 million

TTM EPS

-
CEROW TTM earnings per share value is unknown

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$10.90 M
CEROW annual EBITDA is -$10.90 million

Annual Net Income

-$11.83 M
CEROW annual net profit is -$11.83 million

Annual Interest Expense

-
CEROW annual interest expense value is unknown

Annual Income Tax

-
CEROW annual income tax value is unknown

Annual D&A

$1.07 M
CEROW annual depreciation & amortization is $1.07 million

CEROW EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-0.2%+20.9%-43.4%
3 y3 years-0.2%-111.2%-378.2%
5 y5 years-0.2%-111.2%-378.2%

CEROW EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+0.2%at low+217.5%+26.4%+378.2%at low
5 y5-year+0.2%at low+217.5%+26.4%+378.2%at low
alltimeall time+0.2%at low+217.5%+26.4%+378.2%at low

CERo Therapeutics Holdings EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4.57 M(-20.9%)
-$10.35 M(+43.4%)
Jun 2024
-
-$5.78 M(+301.3%)
-$7.22 M(+20.3%)
Sep 2023
-
-$1.44 M(-39.9%)
-$6.00 M(+31.6%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$2.40 M(+10.8%)
-$4.56 M(+110.8%)
Mar 2023
-
-$2.16 M
-$2.16 M
Dec 2022
-$10.90 M(+0.2%)
-
-
Dec 2021
-$10.88 M
-
-

FAQ

  • What is CERo Therapeutics Holdings annual EBITDA?
  • What is the all time high annual EBITDA for CERo Therapeutics Holdings?
  • What is CERo Therapeutics Holdings annual EBITDA year-on-year change?
  • What is CERo Therapeutics Holdings quarterly EBITDA?
  • What is the all time high quarterly EBITDA for CERo Therapeutics Holdings?
  • What is CERo Therapeutics Holdings quarterly EBITDA year-on-year change?
  • What is CERo Therapeutics Holdings TTM EBITDA?
  • What is the all time high TTM EBITDA for CERo Therapeutics Holdings?
  • What is CERo Therapeutics Holdings TTM EBITDA year-on-year change?

What is CERo Therapeutics Holdings annual EBITDA?

The current annual EBITDA of CEROW is -$10.90 M

What is the all time high annual EBITDA for CERo Therapeutics Holdings?

CERo Therapeutics Holdings all-time high annual EBITDA is -$10.88 M

What is CERo Therapeutics Holdings annual EBITDA year-on-year change?

Over the past year, CEROW annual EBITDA has changed by -$17.56 K (-0.16%)

What is CERo Therapeutics Holdings quarterly EBITDA?

The current quarterly EBITDA of CEROW is -$4.57 M

What is the all time high quarterly EBITDA for CERo Therapeutics Holdings?

CERo Therapeutics Holdings all-time high quarterly EBITDA is -$1.44 M

What is CERo Therapeutics Holdings quarterly EBITDA year-on-year change?

Over the past year, CEROW quarterly EBITDA has changed by +$1.21 M (+20.88%)

What is CERo Therapeutics Holdings TTM EBITDA?

The current TTM EBITDA of CEROW is -$10.35 M

What is the all time high TTM EBITDA for CERo Therapeutics Holdings?

CERo Therapeutics Holdings all-time high TTM EBITDA is -$2.16 M

What is CERo Therapeutics Holdings TTM EBITDA year-on-year change?

Over the past year, CEROW TTM EBITDA has changed by -$3.13 M (-43.38%)